Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paolo Pozzilli

Showing results (131-140 of 264) with videos related to

Pageof 27
Sort By:
Acta Diabetologica|February 27, 2015
Therapy with proton pump inhibitors in patients with type 2 diabetes is independently associated with improved glycometabolic controlIlaria Barchetta, Chiara Guglielmi, Laura Bertoccini, et al.
Diabetes|September 8, 2011
C-peptide response and HLA genotypes in subjects with recent-onset type 1 diabetes after immunotherapy with DiaPep277: an exploratory studyRaffaella Buzzetti, Simona Cernea, Antonio Petrone, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|June 14, 2003
TNF-alpha and growth hormone resistance in patients with chronic liver diseaseAntonio Picardi, Umberto Vespasiani Gentilucci, Enrico Maria Zardi, et al.
Circulation|September 14, 2016
Clopidogrel Versus Ticagrelor for Antiplatelet Maintenance in Diabetic Patients Treated With Percutaneous Coronary Intervention: Results of the CLOTILDIA Study (Clopidogrel High Dose Versus Ticagrelor for Antiplatelet Maintenance in Diabetic Patients)Fabio Mangiacapra, Elena Panaioli, Iginio Colaiori, et al.
The Journal of Clinical Endocrinology and Metabolism|July 3, 2020
The Vicious Circle of Left Ventricular Dysfunction and Diabetes: From Pathophysiology to Emerging TreatmentsIlaria Cavallari, Ernesto Maddaloni, Silvia Pieralice, et al.
Diabetes, Obesity & Metabolism|June 9, 2022
C-peptide determination in the diagnosis of type of diabetes and its management: A clinical perspectiveErnesto Maddaloni, Geremia B Bolli, Brian M Frier, et al.
Diabetes, Obesity & Metabolism|March 16, 2017
Placebo-controlled, randomized trial of the addition of once-weekly glucagon-like peptide-1 receptor agonist dulaglutide to titrated daily insulin glargine in patients with type 2 diabetes (AWARD-9)Paolo Pozzilli, Paul Norwood, Esteban Jódar, et al.
Journal of the American College of Nutrition|July 7, 2011
Dietary pattern and bone density changes in elderly women: a longitudinal studyClaudio Pedone, Nicola Napoli, Paolo Pozzilli, et al.
Current Diabetes Reports|October 30, 2018
Comparison of Lipid-Lowering Medications and Risk for Cardiovascular Disease in DiabetesIlaria Cavallari, Alessia Delli Veneri, Ernesto Maddaloni, et al.
Rejuvenation Research|July 9, 2013
Bone health as a function of adipokines and vitamin D pattern in elderly patientsClaudio Pedone, Nicola Napoli, Paolo Pozzilli, et al.
Pageof 27

Showing results (131-140 of 264) with videos related to

Sort By:
Pageof 27
Acta Diabetologica|February 27, 2015
Therapy with proton pump inhibitors in patients with type 2 diabetes is independently associated with improved glycometabolic controlIlaria Barchetta, Chiara Guglielmi, Laura Bertoccini, et al.
Diabetes|September 8, 2011
C-peptide response and HLA genotypes in subjects with recent-onset type 1 diabetes after immunotherapy with DiaPep277: an exploratory studyRaffaella Buzzetti, Simona Cernea, Antonio Petrone, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|June 14, 2003
TNF-alpha and growth hormone resistance in patients with chronic liver diseaseAntonio Picardi, Umberto Vespasiani Gentilucci, Enrico Maria Zardi, et al.
Circulation|September 14, 2016
Clopidogrel Versus Ticagrelor for Antiplatelet Maintenance in Diabetic Patients Treated With Percutaneous Coronary Intervention: Results of the CLOTILDIA Study (Clopidogrel High Dose Versus Ticagrelor for Antiplatelet Maintenance in Diabetic Patients)Fabio Mangiacapra, Elena Panaioli, Iginio Colaiori, et al.
The Journal of Clinical Endocrinology and Metabolism|July 3, 2020
The Vicious Circle of Left Ventricular Dysfunction and Diabetes: From Pathophysiology to Emerging TreatmentsIlaria Cavallari, Ernesto Maddaloni, Silvia Pieralice, et al.
Diabetes, Obesity & Metabolism|June 9, 2022
C-peptide determination in the diagnosis of type of diabetes and its management: A clinical perspectiveErnesto Maddaloni, Geremia B Bolli, Brian M Frier, et al.
Diabetes, Obesity & Metabolism|March 16, 2017
Placebo-controlled, randomized trial of the addition of once-weekly glucagon-like peptide-1 receptor agonist dulaglutide to titrated daily insulin glargine in patients with type 2 diabetes (AWARD-9)Paolo Pozzilli, Paul Norwood, Esteban Jódar, et al.
Journal of the American College of Nutrition|July 7, 2011
Dietary pattern and bone density changes in elderly women: a longitudinal studyClaudio Pedone, Nicola Napoli, Paolo Pozzilli, et al.
Current Diabetes Reports|October 30, 2018
Comparison of Lipid-Lowering Medications and Risk for Cardiovascular Disease in DiabetesIlaria Cavallari, Alessia Delli Veneri, Ernesto Maddaloni, et al.
Rejuvenation Research|July 9, 2013
Bone health as a function of adipokines and vitamin D pattern in elderly patientsClaudio Pedone, Nicola Napoli, Paolo Pozzilli, et al.
Pageof 27